Phoenix WinNonlin

Phoenix WinNonlin DEV

Phoenix WinNonlin 8.1: The Industry Standard for NCA and PK/PD Modeling and Simulation Phoenix® WinNonlin® is the industry standard for non-compartmental analysis (NCA), pharmacokinetic/pharmacodynamic (PK/PD), and toxicokinetic (TK) modeling. Integrated tools for data processing, post-analysis processing, table creation, and graphics create an all-in-one collaboration workbench used by scientists, reviewers, medical writers, and quality assurance staff for […]

Read More
Topics:

Using M&S to Evaluate Oncology Drug Dosing

Maria Saluta

There are numerous challenges in developing oncology drugs: (1) they are often very toxic which precludes conducting clinical trials in healthy volunteers, (2) the PK of a drug may be altered in cancer patients due to demographic and physiological differences as compared to healthy volunteers, and (3) cancer patients face elevated drug-drug interaction (DDI) risk […]

Read More
Topics: Clinical Pharmacology Strategy, PBPK Modeling & Simulation, PK/PD Modeling & Simulation

Product Demos

Product Demo Schedule Accelerating Drug Discovery with D360 Date: Wednesday, July 19th, 2017 Time: 11:30 am to noon ET See how D360 allows you to make better use of data with spreadsheets for easy SAR or a form view to examine data for individual compounds  Find out how D360 supports compound prioritization and design with SAR analysis […]

Read More
Topics:

Phoenix WinNonlin

Phoenix WinNonlin 8.1: The Industry Standard for NCA and PK/PD Modeling and Simulation Phoenix® WinNonlin® is the industry standard for non-compartmental analysis (NCA), pharmacokinetic/pharmacodynamic (PK/PD), and toxicokinetic (TK) modeling. Integrated tools for data processing, post-analysis processing, table creation, graphics, and compliance create an all-in-one collaboration workbench used by scientists, reviewers, medical writers, and quality assurance staff […]

Read More
Topics:
Learn More LinkedIn Twitter Facebook Email Subscribe to the Blog